Clinical Trials Directory

Trials / Completed

CompletedNCT02748811

Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

GERICO is a randomized, controlled prospective trial. The aim is to investigate if frail, elderly patients with stage II-IV colorectal cancer, will profit from full comprehensive geriatric assessment and intervention before and during treatment with chemotherapy. The hypotheses are: Optimizing the health conditions and functional status of frail elderly patients who suffers from stage II-IV colorectal cancer, with geriatric intervention will lead to a higher grade of completing the planned chemotherapy and at higher dose intensity. This will also result in a higher overall survival and improve quality of life.

Conditions

Interventions

TypeNameDescription
OTHERIntervention groupThe intervention group also receives standard treatment with 6 months of adjuvant chemotherapy or first -line chemotherapy until operation, other scheduled change of treatment or progression. The participants will simultaneously receive full geriatric assessement and intervention. The clinical examination includes laboratory parameters, review of medication list, psycho-cognitive assessement, screening for malnutrition and need of physiotherapy, optimizing social support. Validated quality of life questionnaires will be filled in prior to start, after 2 months and at the end of treatment.

Timeline

Start date
2015-05-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2016-04-22
Last updated
2019-09-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02748811. Inclusion in this directory is not an endorsement.